Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP11353.RARy2Afmpctkep32CwIAgRDeOt8sKeIRp4YfP8najaBAc130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP11353.RARy2Afmpctkep32CwIAgRDeOt8sKeIRp4YfP8najaBAc130_provenance.
• NP164066.RAQqPc7e5cUMNEcLQuiaEWb6mLIUiOYC5rRHdFRtvW5VY130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP164066.RAQqPc7e5cUMNEcLQuiaEWb6mLIUiOYC5rRHdFRtvW5VY130_provenance.
• NP47049.RAFSA8mq5bf9z8ParexAhFNBln-8LgEwguZ3QZqXx0m8k130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP47049.RAFSA8mq5bf9z8ParexAhFNBln-8LgEwguZ3QZqXx0m8k130_provenance.
• NP893872.RAc9fqCc9ovLtm0VicoF4ua1sgOKxa-vrQrJsUcWGkp08130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893872.RAc9fqCc9ovLtm0VicoF4ua1sgOKxa-vrQrJsUcWGkp08130_provenance.
• NP827517.RAgIaHEpjflYpdfHCYApJfKFigK2dxtz-lDRNMF1P6Y5k130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827517.RAgIaHEpjflYpdfHCYApJfKFigK2dxtz-lDRNMF1P6Y5k130_provenance.
• NP764201.RAXNfqGuv6jxKKXXD3uQkh18onP187j5ygPmxt2ac3YrY130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764201.RAXNfqGuv6jxKKXXD3uQkh18onP187j5ygPmxt2ac3YrY130_provenance.
• assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP534170.RAKoXkIn16zqz8OJGZDKka7LA34f321-4sJG5WDr4E5qg130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534170.RAKoXkIn16zqz8OJGZDKka7LA34f321-4sJG5WDr4E5qg130_provenance.
• NP551714.RAGXITwqWQDy5X-NfzijaIr2j8kgFO3-QqzkRc0s1M0HI130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551714.RAGXITwqWQDy5X-NfzijaIr2j8kgFO3-QqzkRc0s1M0HI130_provenance.
• NP905062.RAbIcGCXgADASLTqGsJ4NwmOh-MhqfM4uoXDLyFkZh8Zc130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905062.RAbIcGCXgADASLTqGsJ4NwmOh-MhqfM4uoXDLyFkZh8Zc130_provenance.
• NP9869.RAg6GruQdxkMp-FjFa3ZLRTUYVIy_YLulwRIomKQnBIDg130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP9869.RAg6GruQdxkMp-FjFa3ZLRTUYVIy_YLulwRIomKQnBIDg130_provenance.
• NP431624.RAfY4wit7iIBun0Bo1fWYhNMQuPryyLqXP35dZ9-jvfac130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431624.RAfY4wit7iIBun0Bo1fWYhNMQuPryyLqXP35dZ9-jvfac130_provenance.
• NP431628.RAZU08odmQpxW-YFnUo4Q2rxqZG0WpvRtuhSKZf0ktBhY130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431628.RAZU08odmQpxW-YFnUo4Q2rxqZG0WpvRtuhSKZf0ktBhY130_provenance.
• NP299840.RAqQOlQ81dDIJRqRknMvN74rN5ju2e8vauVZg-DI1msZw130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299840.RAqQOlQ81dDIJRqRknMvN74rN5ju2e8vauVZg-DI1msZw130_provenance.
• NP431625.RApU5Ts_o73RuQMuNU7maYjgJjmnopeD2U9lQRSmYGMAA130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431625.RApU5Ts_o73RuQMuNU7maYjgJjmnopeD2U9lQRSmYGMAA130_provenance.
• NP431626.RAkbyutoe82xD9s8m0dafXintPj3xe9zlqW27Vy3BYwAg130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431626.RAkbyutoe82xD9s8m0dafXintPj3xe9zlqW27Vy3BYwAg130_provenance.
• NP431629.RAhasKV8IJ2zn3dTVdqp0ypEN7bRHDcClCyS4sc-smabE130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431629.RAhasKV8IJ2zn3dTVdqp0ypEN7bRHDcClCyS4sc-smabE130_provenance.
• NP904917.RAE3U6dTHwN_ZURqBWFtyYTYoaruCldo_RbX_BvuJCn2o130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904917.RAE3U6dTHwN_ZURqBWFtyYTYoaruCldo_RbX_BvuJCn2o130_provenance.
• NP431627.RA1HaKyOqTdBbwfHzPpF7R5Zvx8tUZ8fxzpTpfAmn45-Q130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431627.RA1HaKyOqTdBbwfHzPpF7R5Zvx8tUZ8fxzpTpfAmn45-Q130_provenance.
• NP904945.RA6IgZPQ6ZLi3Jr-FMfyT9q7f3254y_zzdv1WdXBd8Bog130_assertion description "[Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904945.RA6IgZPQ6ZLi3Jr-FMfyT9q7f3254y_zzdv1WdXBd8Bog130_provenance.